Zydus receives final approval from the USFDA for Atenolol and Chlorthalidone Tablets USP
Deepthi | Myequity news | Date : 12-03-2019 12:56:00 IST
Zydus Cadila has received the final approval from the USFDA to market Atenolol and Chlorthalidone Tablets USP (USRLD Tenoretic®), 50mg/25mg and 100mg/25mg. It will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad.
About Zydus Cadila
Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.